ANAQUANT, Villeurbanne, France.
CEA, 17 av. des Martyrs, Grenoble, 38000, France.
Proteomics. 2021 Mar;21(5):e2000152. doi: 10.1002/pmic.202000152. Epub 2021 Feb 23.
Biotherapeutics, molecules produced from biological systems, require rigorous purification steps to remove impurities including host cell proteins (HCPs). Regulatory guidelines require manufacturers to monitor process-related impurities along the purification workflow. Mass spectrometry (MS) has recently been considered as a complementary method to the well-established ELISA for HCPs quantification, since it has the advantage of unambiguously identifying individual HCP. In this study, we developed an innovative standard dedicated to MS-based HCP profiling analysis in order to monitor the consistency of viral vaccine intermediate purification samples. This standard, termed the HCP-PROFILER standard, is composed of a water-soluble bead (READYBEADS technology) which, after being added into the sample, releases unlabeled peptides in controlled amounts. The standard meets three desired criteria: (1) it is composed of multiple peptides, at different concentration levels, allowing construction of a calibration curve covering the dynamic range of HCPs present in the target sample, ensuring quantification accuracy; (2) it demonstrates high batch-to-batch reproducibility, ensuring quantification robustness and consistency over time; and (3) it is easy to use and avoids user-induced analytical biases. In this study, we present the use of the HCP-PROFILER standard for vaccine batches comparison and downstream process performance studies.
生物疗法药物是从生物系统中产生的分子,需要严格的纯化步骤来去除杂质,包括宿主细胞蛋白 (HCP)。监管指南要求制造商沿纯化工作流程监测与工艺相关的杂质。质谱 (MS) 最近已被认为是 ELISA 定量 HCP 的补充方法,因为它具有明确识别单个 HCP 的优势。在这项研究中,我们开发了一种创新的标准,专门用于基于 MS 的 HCP 分析,以监测病毒疫苗中间纯化样品的一致性。该标准称为 HCP-PROFILER 标准,由水溶性珠子(READYBEADS 技术)组成,加入样品后,以受控的量释放未标记的肽。该标准符合三个理想的标准:(1) 它由多种肽组成,浓度水平不同,允许构建涵盖目标样品中存在的 HCP 动态范围的校准曲线,确保定量准确性;(2) 它具有高度的批间重现性,确保随着时间的推移具有稳健和一致的定量;(3) 它易于使用,避免了用户引起的分析偏差。在这项研究中,我们展示了 HCP-PROFILER 标准在疫苗批次比较和下游工艺性能研究中的应用。